The biopsy channel of the colonoscope was used in a novel approach to the study of in vivo colonic nitrogen metabolism in 12 subjects. A tracer dose of 15N15N-urea was placed in the caecum in six and distal to the splenic flexure in six. The urine and stool were coliected for 72 hours and isotopic enrichment was measured in a mass spectrometer. A similar proportion of the dose was recovered in the urine as 15N15N-urea from the right colon, 6%, as was recovered from the left, 4%, showing that the urea was absorbed intact. Urinary 15N14N-urea from the right colon was 18% of the dose compared to 13% from the left colon. This represents urea that has been hydrolysed and absorbed as ammonia. Less than 4% of the dose was recovered in the stool. The greatest proportion of the label, 74% from the right and 82% from the left, could not be accounted for in the urine or the stool and is presumed to have entered the metabolic pool of nitrogen. We conclude that; the colon is permeable to urea, intraluminal hydrolysis occurs and that urea nitrogen enters the metabolic pool of nitrogen in functionally significant quantities.
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The mechanism of adaptation to low protein intakes involves the retention and salvaging of urea nitrogen, which is hydrolysed in the lower bowel rather than being excreted in the urine. ' The metabolic handling of nitrogen in the bowel has direct relevance to a number of clinical situations, most obviously hepatic failure with portosystemic encephalopathy, and chronic renal failure.
Our understanding of the metabolism of urea by the human colon has been dominated by the observations of Wolpert et a12 and Bown et al. 3 Wolpert et al,2 using a steady state perfusion of the intact colon, found that only 2% of plasma urea was recovered from the lumen of the colon, whereas 5% of urea perfused into the colon could be accounted for by absorption. They concluded that trivial amounts of urea are excreted and hydrolysed in the lumen; the colon is effectively impermeable to urea, and that any hydrolysis that takes place is likely to be juxtamucosal rather than luminal. Bown et aP3 perfused the excluded colon at 10 ml/min, were unable to show either luminal or juxtamucosal hydrolysis and found limited permeability of the colonic mucosa to urea.
Since the earlier work of Walser and Bodenlos4 it had been clear that in the normal adult only about 70% of the urea production is excreted in the urine, with the other 30% being hydrolysed and a proportion of this being retained by the body. There is substantial evidence showing that the retained urea is hydrolysed in the large bowel by the microflora.' There are two possible ways in which urea might reach the microflora; through the ileocaecal valve or by passing through the colonic wall. Chadwick et al6 measured the flux of urea from the ileum to the colon as 0-35 g urea nitrogen per day, only a small proportion of the daily breakdown in the colon. They concluded that substantial quantities must be excreted directly into the colon from the blood. Gibson et al were able to show that the 0 39 g urea nitrogen passing through the ileocaecal valve was only a fraction of the daily ureolysis, 2-9 to 5-1 g nitrogen per day. They formed the opinion that only a minor part of the ureolysis took place in the colonic lumen. Wrong et a18 used 15N1SN labelled urea to measure the rate of urea synthesis, and hydrolysis, and based on the relative enrichment of faecal nitrogen, they also concluded that the lumen of the large bowel is not the main site of endogenous urea hydrolysis.
The findings of these studies conflict with the practical experience that modulating the metabolic activity of the gastrointestinal microflora, by the use of antibiotics, or the provision of energy substrate in the form of non-digestible, fermentable carbohydrate is a central factor in the alleviation of hepatic encephalopathy.9 In more recent studies we have found that, in fact, urea nitrogen traces the movement of a far larger pool of nitrogen through the bowel, of the order of 16 30N-urea will appear in the urine. Any urea that is hydrolysed in the bowel will give rise to 15N labelled ammonia, which may be absorbed and reincorporated into urea, containing one labelled and one unlabelled nitrogen, 15N14N-urea, or 29N-urea. The appearance of 29N-urea gives a measure of the extent of colonic urea hydrolysis.
The nitrogen from hydrolysed urea may be utilised for the metabolic activity of the colonic microflora or of the host, and it has been presumed that label that cannot be accounted for in urine and stool has been utilised for synthetic activities.
We have been able to show that the colon is permeable to urea, and that a substantial proportion of the urea nitrogen placed in the lumen of the colon can be retained by the host. These data imply that the metabolism of nitrogen in the lower bowel may be of far greater functional significance than has been appreciated heretofore.
Methods

SUBJECTS
The subjects for the study were 12 of 14 male patients who were admitted for diagnostic colonoscopy. From their history it was considered that these patients were unlikely to have gross colonic pathology and they were invited to participate. They agreed that the study could be carried out if, at colonoscopy, the colon was found to be unremarkable. The purpose of the study was explained and each gave their permission for the study in the full recognition that they could withdraw at any time without prejudice. The Southampton Hospitals' Ethical Committee gave approval for the conduct of the study. Two patients, with a history of a change in bowel habit, were excluded because they had macroscopic colitis at colonoscopy which required mucosal biopsy. This left a total of 12 subjects who had a normal colon. Bowel preparation included a low residue diet for two days before the examination; on the day before colonoscopy sennosides 1 mg/kg (X-Prep, Napp Laboratories) and picosulphate, 10 mg (Picolax, Ferring pharmaceuticals). On the morning of the examination picosulphate, 10 mg, was taken and oral intake was then restricted to clear fluids. It was possible to see the whole colon in all cases.
A sample of urine was collected from all subjects before the examination for the measurement of baseline enrichment in urea. A measured dose of 30N-urea (97 7 atom % 15N, MSD Isotopes, Canada) was dissolved in normal saline. At the completion of the colonoscopy 1I5 mg/kg of 30N-urea was injected through the biopsy channel of the colonoscope; into the caecum in six and distal to the splenic flexure in six. The isotope was flushed through with 10 in Figure 2 together with the amount of label excreted in milligrams over time. The label was excreted as both 30N-urea and 29N-urea in all subjects, although there was variation between individuals. The percentage of the dose excreted as urinary 30N-urea in the 12 subjects is shown in Figure 3 . A similar proportion of the dose was recovered from the right colon, 6%, as was recovered from the left colon, 4%.
The Table shows l5N was absorbed and retained. The implication of these observations is that the colonic wall is permeable to the intact amino acids, derived from the yeast proteins, after digestion by the colonic microflora and that these amino acids are absorbed in significant quantities.
One possible interpretation of our data is that the microflora can utilise the urea instilled into the colon to satisfy their nitrogen requirements for amino acid synthesis; these amino acids then being available to the host. If a large proportion was retained within the bacterial cell then a far greater amount would have been recovered in the stool. This interpretation is in keeping with our earlier suggestion that the metabolic activity of the colonic flora may play an important role in the provision of essential and non-essential amino acids to the host, and that this function represents an important point of interaction between dietary fibre and protein requirements. 2 Colonoscopy requires a bowel preparation, therefore the colon does not have its normal bacterial flora. Our findings, however, taken in conjunction with those of Heine et all' suggest that the absorptive capacity of the human colon has been underestimated by perfusion studies. It is likely that the intestinal flora affects the colonic handling ofurea and the results may be markedly different in the presence of a normal mass of colonic microflora. 
